Director Offer Letter - Entropic Communications Inc. and Kenneth Merchant
March 25, 2007
Mr. Kenneth Merchant
28 Normandy Court
La Cañada, CA 91011
Dear Ken:
This letter outlines the terms of a proposed appointment of you to an open board of directors seat at Entropic Communications, Inc. (the "Company").
1. | Stock Option. In connection with your acceptance as a member of the board of directors of the Company, the Company will grant you an option to purchase 320,000 shares of the Company's Common Stock with an exercise price equal to fair market value on the date of the grant. These option shares will vest over a four-year period with a 25% one-year cliff, in accordance with the standard option plan approved by the Company's board of directors. Vesting will, of course, depend on your continued service as a member of the board of directors with the Company. The option will be a nonstatutory stock option and will be subject to the terms of the Company's 2001 Stock Option Plan and the Stock Option Agreement between you and the Company. |
2. | Expense Reimbursement. The Company shall promptly reimburse you for all expenses associated with your attendance at the Company's board of directors meetings providing that (i) the expenditures are of a nature qualifying them as legitimate and reasonable business expenses, and (ii) you furnish to the Company adequate records and other documentary evidence reasonably required by the Company to substantiate the expenditures. |
3. | Change of Control. In the case of a Change of Control of the Company, if a board seat in the surviving company is not offered to you, vesting would be accelerated for 100 percent for any unvested stock options then held by you. A "Change in Control" means: (i) the direct or indirect sale or exchange in a single or series of related transactions by the stockholders of Entropic of more than fifty percent (50%) of the voting stock of Entropic; (ii) a merger or consolidation in which Entropic is a party after which the stockholders of Entropic immediately prior to such transaction hold less than fifty percent (50%) of the voting securities of the |
9276 Scranton Road, Suite 200 • San Diego, CA 92121 • 858.625.3200 Main / 858.546.2409 Fax
surviving entity; (iii) the sale, exchange, or transfer of all or substantially all of the assets of Entropic after which the stockholders of Entropic immediately prior to such transaction hold less than fifty percent (50%) of the voting securities of the corporation or other business entity to which the assets of Entropic were transferred; or (iv) a liquidation or dissolution of Entropic.
4. | Duration of Appointment. The Company expects your commitment to the Company will be for four years from the date of appointment. If you resign or you are removed from the board by a shareholder vote, vesting of your stock option will cease. |
5. | D&O Insurance. The Company will provide you with the appropriate board of directors insurance. |
If you accept this offer, your first day as an Entropic board member will be later this week when the Board approves your election by written consent. We have an in-person board meeting on April 17, but prior to that date we will have a telephonic meeting to approve a pending merger. To bring you up to speed I would be happy to brief you on the proposed acquisition at your first convenience. The board of directors is expected to approve your stock option grant on April 17 and appoint you to chair the Entropic Audit Committee on that date.
We hope that you find the foregoing terms acceptable. You may indicate your agreement with these terms by signing and dating the enclosed duplicate original of this letter agreement and returning it to me.
Ken, we look forward with enthusiasm to your acceptance of our offer and to the commencement of your duties as a member of the board of directors of the Company.
Sincerely,
/s/ Patrick C. Henry |
Patrick Henry |
President & CEO |
Entropic Communications, Inc. |
Agreed and acknowledged: | ||
By: |
/s/ Kenneth C. Merchant |
|
Kenneth Merchant | ||
Dated: March 27, 2007 |
9276 Scranton Road, Suite 200 •San Diego, CA 92121 • 858.625.3200 Main / 858.546.2409 Fax